{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:18:04Z","timestamp":1792894684337,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019211","name":"Institute of Engineering Research, Seoul National University","doi-asserted-by":"publisher","award":["3-22-08"],"award-info":[{"award-number":["3-22-08"]}],"id":[{"id":"10.13039\/501100019211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["R03AA031063"],"award-info":[{"award-number":["R03AA031063"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bcp.2024.116516","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:08:21Z","timestamp":1725037701000},"page":"116516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ketamine \u2013 An Imperfect Wonder Drug?"],"prefix":"10.1016","volume":"229","author":[{"given":"Tanner","family":"Magruder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Isenhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximillian V.","family":"Striepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mannisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karry M.","family":"Jannie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"McCarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-956X","authenticated-orcid":false,"given":"Vanja","family":"Duric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116516_b0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/jm00326a019","article-title":"The Synthesis of Phencyclidine and Other 1-Arylcyclohexylamines","volume":"8","author":"Maddox","year":"1965","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bcp.2024.116516_b0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"History of anaesthesia: The ketamine story - past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1213\/00000539-196601000-00007","article-title":"Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581","volume":"45","author":"Corssen","year":"1966","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bcp.2024.116516_b0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 Years of Modulating the Mind","volume":"10","author":"Li","year":"2016","journal-title":"Front Hum Neurosci"},{"issue":"5","key":"10.1016\/j.bcp.2024.116516_b0025","first-page":"521","article-title":"Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Cohen","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine\u2013its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cns.12072","article-title":"Ketamine: use in anesthesia","volume":"19","author":"Marland","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/emj.11.3.189","article-title":"Use of ketamine in prolonged entrapment","volume":"11","author":"Cottingham","year":"1994","journal-title":"J Accid Emerg Med"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1399-6576.2008.01852.x","article-title":"Pre-hospital use of ketamine in paediatric trauma","volume":"53","author":"Bredmose","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bcp.2024.116516_b0055","series-title":"Ketofol for procedural sedation?","first-page":"444","author":"Green","year":"2011"},{"key":"10.1016\/j.bcp.2024.116516_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109171","article-title":"Ketamine; history and role in anesthetic pharmacology","volume":"216","author":"Hirota","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/20961790.2017.1285219","article-title":"Metabolism and metabolomics of ketamine: a toxicological approach","volume":"2","author":"Dinis-Oliveira","year":"2017","journal-title":"Forensic Sci Res"},{"key":"10.1016\/j.bcp.2024.116516_b0070","doi-asserted-by":"crossref","unstructured":"B. Sinner, B.M. Graf, Ketamine, Handb Exp Pharmacol (182) (2008) 313-33.","DOI":"10.1007\/978-3-540-74806-9_15"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","article-title":"Expanding Role of NMDA Receptor Antagonists in the Management of Pain","volume":"33","author":"Kreutzwiser","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2024.116516_b0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.aan.2020.07.005","article-title":"Update on Ketamine","volume":"38","author":"Zhou","year":"2020","journal-title":"Adv Anesth"},{"issue":"11","key":"10.1016\/j.bcp.2024.116516_b0085","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AJP.0000000000000635","article-title":"An Update on the Basic and Clinical Science of Ketamine Analgesia","volume":"34","author":"Doan","year":"2018","journal-title":"Clin J Pain"},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0090","first-page":"260","article-title":"Pharmacokinetics of ketamine in man","volume":"24","author":"Wieber","year":"1975","journal-title":"Anaesthesist"},{"issue":"7604","key":"10.1016\/j.bcp.2024.116516_b0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116516_b0100","doi-asserted-by":"crossref","unstructured":"E.F. Domino, Taming the ketamine tiger. 1965, Anesthesiology 113(3) (2010) 678-84.","DOI":"10.1097\/ALN.0b013e3181ed09a2"},{"issue":"10","key":"10.1016\/j.bcp.2024.116516_b0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2005.08.006","article-title":"Emerging molecular mechanisms of general anesthetic action","volume":"26","author":"Hemmings","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1152\/jn.00210.2019","article-title":"Anesthetics: from modes of action to unconsciousness and neurotoxicity","volume":"122","author":"Iqbal","year":"2019","journal-title":"J. Neurophysiol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0115","first-page":"489","article-title":"Update on the Physiologic Effects of Ketamine in General Anesthesia and Spinal Blockade: A Review of the Literature","volume":"87","author":"Ragule","year":"2019","journal-title":"Aana j"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0120","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2024.116516_b0125","doi-asserted-by":"crossref","unstructured":"S.P. Cohen, L. Vase, W.M. Hooten, Chronic pain: an update on burden, best practices, and new advances, Lancet (London, England) 397(10289) (2021).","DOI":"10.1016\/S0140-6736(21)00393-7"},{"issue":"36","key":"10.1016\/j.bcp.2024.116516_b0130","article-title":"Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016, MMWR","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0135","doi-asserted-by":"crossref","DOI":"10.1097\/00000542-200310000-00033","article-title":"Synergistic antinociceptive effects of ketamine and morphine in the orofacial capsaicin test in the rat","volume":"99","author":"Alvarez","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bcp.2024.116516_b0140","doi-asserted-by":"crossref","unstructured":"M.E. Lynch, A.J. Clark, J. Sawynok, S.M. J, Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study, The journal of pain 6(10) (2005).","DOI":"10.1016\/j.jpain.2005.04.008"},{"key":"10.1016\/j.bcp.2024.116516_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-6-50","article-title":"Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain","volume":"6","author":"Mei","year":"2010","journal-title":"Molecular Pain"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0150","doi-asserted-by":"crossref","DOI":"10.1213\/01.ANE.0000131729.54986.30","article-title":"Reduced sensitivity to ketamine and pentobarbital in mice lacking the N-methyl-D-aspartate receptor GluRepsilon1 subunit","volume":"99","author":"Petrenko","year":"2004","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0155","doi-asserted-by":"crossref","DOI":"10.4103\/2279-042X.155758","article-title":"Midazolam premedication for Ketamine-induced emergence phenomenon: A prospective observational study","volume":"4","author":"Perumal","year":"2015","journal-title":"Journal of Research in Pharmacy Practice"},{"issue":"9","key":"10.1016\/j.bcp.2024.116516_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2007.12.005","article-title":"Adverse events associated with ketamine for procedural sedation in adults","volume":"26","author":"Strayer","year":"2008","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0165","doi-asserted-by":"crossref","DOI":"10.31486\/toj.21.0038","article-title":"Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia","volume":"21","author":"Pastrak","year":"2021","journal-title":"Ochsner Journal"},{"key":"10.1016\/j.bcp.2024.116516_b0170","doi-asserted-by":"crossref","unstructured":"S. Liman, C.W. Cheung, K.L. Wong, W. Tai, Q. Qiu, K. Ng, Fu, S.W. Choi, M. Irwin, Preventive Treatment with Ketamine Attenuates the Ischaemia-Reperfusion Response in a Chronic Postischaemia Pain Model, Oxidative medicine and cellular longevity 2015 (2015).","DOI":"10.1155\/2015\/380403"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0175","article-title":"Effect of intravenous patient controlled ketamine analgesiaon postoperative pain in opium abusers","volume":"4","author":"Dahi-Taleghan","year":"2014","journal-title":"Anesthesiology and Pain Medicine"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/SPC.0000000000000055","article-title":"Descending pain modulation and chronification of pain","volume":"8","author":"Ossipov","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(24)38236-9","article-title":"Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain","volume":"289","author":"Rabben","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0190","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12614","article-title":"CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects","volume":"80","author":"Li","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0195","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"129","author":"Orhurhu","year":"2019","journal-title":"Anesth. Analg."},{"issue":"5","key":"10.1016\/j.bcp.2024.116516_b0200","doi-asserted-by":"crossref","DOI":"10.1097\/PR9.0000000000000674","article-title":"Ketamine for pain management","volume":"3","author":"Bell","year":"2018","journal-title":"Pain Reports"},{"issue":"8","key":"10.1016\/j.bcp.2024.116516_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/da.22536","article-title":"A REVIEW OF KETAMINE ABUSE AND DIVERSION","volume":"33","author":"Sassano-Higgins","year":"2016","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/0304-3959(94)90149-X","article-title":"Response of chronic neuropathic pain syndromes to ketamine: a preliminary study","volume":"56","author":"Backonja","year":"1994","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0215","doi-asserted-by":"crossref","DOI":"10.11607\/ofph.1973","article-title":"Analgesic Effects of Intranasal Ketamine in Rat Models of Facial Pain","volume":"32","author":"Claudino","year":"2018","journal-title":"J. Oral Facial Pain Headache"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0220","doi-asserted-by":"crossref","DOI":"10.4097\/kjae.2012.62.1.66","article-title":"Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats","volume":"62","author":"Hwang","year":"2012","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.bcp.2024.116516_b0225","doi-asserted-by":"crossref","unstructured":"S. Patil, M. Anitescu, Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis, Pain medicine (Malden, Mass.) 13(2) (2012).","DOI":"10.1111\/j.1526-4637.2011.01241.x"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0230","doi-asserted-by":"crossref","DOI":"10.1007\/s00540-013-1722-5","article-title":"Subanalgesic ketamine enhances morphine-induced antinociceptive activity without cortical dysfunction in rats","volume":"28","author":"Shikanai","year":"2014","journal-title":"J. Anesth."},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0235","doi-asserted-by":"crossref","DOI":"10.1097\/00000539-200112000-00031","article-title":"The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception","volume":"93","author":"Sarton","year":"2001","journal-title":"Anesth. Analg."},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0240","doi-asserted-by":"crossref","DOI":"10.3109\/15360288.2014.938881","article-title":"Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain","volume":"28","author":"Amin","year":"2014","journal-title":"Journal of Pain & Palliative Care Pharmacotherapy"},{"issue":"29","key":"10.1016\/j.bcp.2024.116516_b0245","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.42.1081","article-title":"Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain","volume":"30","author":"Hardy","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0250","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-012-1020-7","article-title":"Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes","volume":"70","author":"Duric","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"23","key":"10.1016\/j.bcp.2024.116516_b0255","doi-asserted-by":"crossref","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0260","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiat."},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0270","article-title":"Treatment-resistant depression","volume":"80","author":"Little","year":"2009","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0275","article-title":"Ketamine for resistant depression: a scoping review","volume":"50","author":"Tuta-Quintero","year":"2022","journal-title":"Actas Espanolas De Psiquiatria"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bcp.2024.116516_b0285","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2024.116516_b0290","doi-asserted-by":"crossref","DOI":"10.1177\/0269881114544776","article-title":"Hippocampal volume and the rapid antidepressant effect of ketamine","volume":"29","author":"Abdallah","year":"2015","journal-title":"Journal of Psychopharmacology (oxford, England)"},{"key":"10.1016\/j.bcp.2024.116516_b0295","article-title":"Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies","volume":"293","author":"Hong","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2024.116516_b0300","doi-asserted-by":"crossref","unstructured":"M. Abbar, Ketamine for the acute treatment of severe suicidal ideation:: double blind, randomised placebo controlled trial, in: W.E.-H. Christophe Demattei, Pierre-Michel Llorca, Ludovic Samalin, Pierre Demaricourt, Raphael Gaillard, Philippe Courtet, Guillaume Vaiva, Philip Gorwood 5, Pascale Fabbro, Fabrice Jollant (Ed.) BMJ, online, 2022.","DOI":"10.1136\/bmj-2021-067194"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0305","article-title":"S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial","volume":"22","author":"Yaquin","year":"2022","journal-title":"BMC Anesthesiol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116516_b0310","article-title":"Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial","volume":"47","author":"Abdallah","year":"2022","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.bcp.2024.116516_b0315","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13096","article-title":"Association between depression subtypes and response to repeated-dose intravenous ketamine","volume":"140","author":"Wang","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"10.1016\/j.bcp.2024.116516_b0320","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2024.116516_b0325","doi-asserted-by":"crossref","unstructured":"F.S. Correia-Melo, G.C. Leal, F.\u00e1. Vieira, A.P. Jesus-Nunes, R.P. Mello, G. Magnavita, A.T. Caliman-Fontes, M.V.F. Echegaray, I.D. Bandeira, S.S. Silva, D.E. Cavalcanti, L. Ara\u00fajo-de-Freitas, L.M. Sarin, M.A. Tuena, C. Nakahira, A.S. Sampaio, J.\u00e9.A. Del-Porto, G. Turecki, C. Loo, A.L.T. Lacerda, L.C. Quarantini, Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study, Journal of affective disorders 264 (2020).","DOI":"10.1016\/j.jad.2019.11.086"},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0330","article-title":"Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant","volume":"44","author":"Bahr","year":"2019","journal-title":"P & T : a Peer-Reviewed Journal for Formulary Management"},{"issue":"12","key":"10.1016\/j.bcp.2024.116516_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126804","article-title":"(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders","volume":"25","author":"Shafique","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7354","key":"10.1016\/j.bcp.2024.116516_b0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116516_b0350","doi-asserted-by":"crossref","unstructured":"N. Li, B. Lee, R.-J. Liu, M. Banasr, J.M. Dwyer, M. Iwata, X.-Y. Li, G. Aghajanian, R.S. Duman, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science (New York, N.Y.) 329(5994) (2010).","DOI":"10.1126\/science.1190287"},{"issue":"9","key":"10.1016\/j.bcp.2024.116516_b0355","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41386-018-0084-y","article-title":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","volume":"43","author":"Yamaguchi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2024.116516_b0360","unstructured":"G. Britain, Drug Misuse: Findings from the 2017\/18 Crime Survey for England and Wales, Home Office, 2018."},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0365","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/070674370204700606","article-title":"Ecstasy and drug consumption patterns: a Canadian rave population study","volume":"47","author":"Gross","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.bcp.2024.116516_b0370","first-page":"1","article-title":"Past-Year Ketamine Use: Evidence from a United States Population, 2015\u20132019","author":"Yockey","year":"2022","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2024.116516_b0375","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1360-0443.2001.96574910.x","article-title":"In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users","volume":"96","author":"Curran","year":"2001","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0380","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0897190014525754","article-title":"Ketamine: an update on its abuse","volume":"27","author":"Bokor","year":"2014","journal-title":"J Pharm Pract"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0385","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-3565(25)11430-4","article-title":"Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors","volume":"260","author":"Oye","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0390","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1523\/JNEUROSCI.3481-08.2009","article-title":"HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine","volume":"29","author":"Chen","year":"2009","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0395","doi-asserted-by":"crossref","DOI":"10.1097\/ALN.0b013e318287b7c8","article-title":"Forebrain HCN1 channels contribute to hypnotic actions of ketamine","volume":"118","author":"Zhou","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bcp.2024.116516_b0400","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2014.03.026","article-title":"Central antinociception induced by ketamine is mediated by endogenous opioids and \u03bc- and \u03b4-opioid receptors","volume":"1562","author":"Pacheco Dda","year":"2014","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0405","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/bja\/82.4.603","article-title":"Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens","volume":"82","author":"Hancock","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bcp.2024.116516_b0410","unstructured":"K. Hashimoto, Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine | Elsevier Enhanced Reader, (2022)."},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.105.015263","article-title":"Psychological effects of ketamine in healthy volunteers","volume":"189","author":"Pomarol-Clotet","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0420","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02791072.1988.10472511","article-title":"The psychotropic effect of ketamine","volume":"20","author":"Hansen","year":"1988","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0425","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1360-0443.2000.9545759.x","article-title":"Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later","volume":"95","author":"Curran","year":"2000","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2008.01.024","article-title":"Journey through the K-hole: phenomenological aspects of ketamine use","volume":"95","author":"Muetzelfeldt","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"9\u201310","key":"10.1016\/j.bcp.2024.116516_b0435","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1081\/JA-200066736","article-title":"Party drugs: properties, prevalence, patterns, and problems","volume":"40","author":"Maxwell","year":"2005","journal-title":"Subst Use Misuse"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/02791072.1996.10524391","article-title":"Illicit use of ketamine in Scotland","volume":"28","author":"Dalgarno","year":"1996","journal-title":"J Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.bcp.2024.116516_b0445","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.aap.2010.07.004","article-title":"The prevalence of drugs in motor vehicle accidents and traffic violations in Shanghai and neighboring cities","volume":"42","author":"Zhuo","year":"2010","journal-title":"Accid Anal Prev"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2024.116516_b0450","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.forsciint.2004.08.023","article-title":"An epidemiological study on alcohol\/drugs related fatal traffic crash cases of deceased drivers in Hong Kong between 1996 and 2000","volume":"153","author":"Cheng","year":"2005","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0455","first-page":"6","article-title":"Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases","volume":"16","author":"Ng","year":"2010","journal-title":"Hong Kong Med J"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0460","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0736-4679(00)00162-1","article-title":"Ketamine abusers presenting to the emergency department: a case series","volume":"18","author":"Weiner","year":"2000","journal-title":"J Emerg Med"},{"issue":"11","key":"10.1016\/j.bcp.2024.116516_b0465","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ajhp\/59.11.1067","article-title":"Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate","volume":"59","author":"Smith","year":"2002","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"10.1016\/j.bcp.2024.116516_b0470","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1464-410X.2008.07920.x","article-title":"The destruction of the lower urinary tract by ketamine abuse: a new syndrome?","volume":"102","author":"Chu","year":"2008","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0475","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1751-2980.2010.00424.x","article-title":"Upper gastrointestinal problems in inhalational ketamine abusers","volume":"11","author":"Poon","year":"2010","journal-title":"J Dig Dis"},{"issue":"5","key":"10.1016\/j.bcp.2024.116516_b0480","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.bcp.2024.116516_b0485","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0960327112436404","article-title":"Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney","volume":"31","author":"Wai","year":"2012","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116516_b0490","first-page":"53","article-title":"Dilated common bile ducts mimicking choledochal cysts in ketamine abusers","volume":"15","author":"Wong","year":"2009","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.bcp.2024.116516_b0495","doi-asserted-by":"crossref","unstructured":"P. Glue, C. Loo, J. Fam, H.Y. Lane, A.H. Young, P. Surman, B.s. investigators, Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial, Nature medicine 30(7) (2024) 2004-2009.","DOI":"10.1038\/s41591-024-03063-x"},{"issue":"3","key":"10.1016\/j.bcp.2024.116516_b0500","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18r12475","article-title":"Oral Ketamine for Depression: A Systematic Review","volume":"80","author":"Rosenblat","year":"2019","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0505","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/17512433.2023.2198703","article-title":"Clinical pharmacological innovation in the treatment of depression","volume":"16","author":"Witkin","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0510","doi-asserted-by":"crossref","first-page":"609","DOI":"10.9758\/cpn.23.1081","article-title":"Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder","volume":"21","author":"McCarthy","year":"2023","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.bcp.2024.116516_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104762","article-title":"(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/emj.8.4.291","article-title":"Ketamine in severe acute asthma","volume":"8","author":"Turnpenny","year":"1991","journal-title":"Arch Emerg Med"},{"issue":"2","key":"10.1016\/j.bcp.2024.116516_b0525","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/bja\/76.2.266","article-title":"Relaxant effect of ketamine and its isomers on histamine-induced contraction of tracheal smooth muscle","volume":"76","author":"Hirota","year":"1996","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0530","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1213\/ANE.0b013e3182662e30","article-title":"Does intraoperative ketamine attenuate inflammatory reactivity following surgery?","volume":"115","author":"Dale","year":"2012","journal-title":"A Systematic Review and Meta-Analysis, Anesth Analg"},{"issue":"4","key":"10.1016\/j.bcp.2024.116516_b0535","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1213\/ANE.0000000000001856","article-title":"In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury","volume":"124","author":"Bell","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bcp.2024.116516_b0540","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","article-title":"Ketamine: its mechanism(s) of action and unusual clinical uses","author":"Hirota","year":"1996","journal-title":"Br J Anaesth, England"},{"key":"10.1016\/j.bcp.2024.116516_b0545","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/bja\/aer221","article-title":"Ketamine: new uses for an old drug?","author":"Hirota","year":"2011","journal-title":"Br J Anaesth, England"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:17:54Z","timestamp":1741713474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224004994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":109,"alternative-id":["S0006295224004994"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116516","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine \u2013 An Imperfect Wonder Drug?","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116516"}}